Induction of apoptosis in glioma cells and upregulation of fas expression using the human interferon-β gene

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 6, 2012, Pages 2837-2840

  Guo, Yan ^a   Wang, Gan ^a   Gao, Wen Wei ^a   Cheng, Shi Wen ^a   Wang, Ren ^a   Ju, Shi Ming ^a   Cao, He Li ^a   Tian, Heng Li ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Apoptosis; Human malignant glioma; Interferon; Therapy;

Indexed keywords

EID: 84874088092     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.6.2837     Document Type: Article

References (18)

1. Buechner SA, Wernli M, Harr T, et al (1997). Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide. J Clin Invest, 100, 2691-6.
2. Dinney CP, Bielenberg DR, Perrotte P, et al (1998). Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by mice by systemic interferon-a administration. Cancer Res, 58, 808-14.
3. Fabra A, Nakajima M, Bucana CD, Fidler IJ (1992). Modulation of the invasive phenotype of human colon carcinoma cells by organ-specific fibroblasts of nude mice. Differentiation, 52, 101-10.
4. Gohji K, Fidler IJ, Tsan R, et al (1994). Human recombinant interferons-b and g decrease gelatinase production and invasion by human KG-2 renal carcinoma cells. Int J Cancer,
5. Hertzog PJ, Hwang SY, Kola I (1994). Role of interferons in the regulation of cell proliferation, differentiation, and development. Mol Reprod Dev, 39, 226-32.
6. Ito S, Natsume A, Shimato S, et al (2010). Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma. Cancer Gene Ther, 17, 299-306.
7. Kageshita T, Mizuno M, Ono T, et al (2001). Growth inhibition of human malignant melanoma transfected with the human interferon-beta gene by means of cationic liposomes. Melanoma Res, 11, 337-42.
8. Konjevic G, Mirjacic Martinovic K, Vuletic A, Babovic N (2010). In-vitro IL-2 or IFN-a-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients. Melanoma Res, 20, 459-67.
9. Koshiji M, Adachi Y, Sogo S, et al (1998). Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factoralpha (TNF-alpha) and/or interferon-gamma (IFN-gamma), resulting from down-modulation of Bcl-2 expression. Clin Exp Immunol, 111, 211-8.
10. Lin W, Zhang X, Wang ZX, et al (2004). Growth inhibition of glioma cell line SHG44 by transfection of human interferonbeta gene liposome. Chin J Neurosurg Dis Res, 3, 226-9.
11. Mizuno M, Yoshida J, Sugita K, et al (1990). Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res, 50, 7826-9.
12. Nakahara N, Pollack IF, Storkus WJ, et al (2003). Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells. Cancer Gene Ther, 10, 549-58.
13. Oliveira IC, Sciavolino PJ, Lee TH (1992). Down regulation of interleukin 8 gene expression in human fibroblasts, unique mechanism of transcriptional inhibition by interferon. Natl Acad Sci USA, 89, 9049-53.
14. Sangfelt O, Erickson S, Castro J, et al (1997). Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines. Cell Growth Differ, 8, 343-52.
15. Singh RK, Gutman M, Bucana CD, et al (1995). Interferons alpha and beta down regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad, 92, 4562-6.
16. Wakabayashi T, Kajita Y, Hatano N, et al (2000). Clinicopathological study of oligodendroglial tumors, the effectiveness of interferon beta, ACNU/MCNU, and radiation (IAR/IMR) for anaplastic tumors. Brain Tumor Pathol, 17, 29-33.
17. Williams RF, Myers AL, Sims TL, Ng CY, Nathwani AC, Davidoff AM (2010). Targeting multiple angiogenic pathways for the treatment of neuroblastoma. J Pediatr Surg, 45, 1103-9.
18. Yoshida J, Mizuno M, Wakabayashi T (2004). Interferon-beta gene therapy for cancer, basic research to clinical application. Cancer Sci, 95, 858-65.